This inventor holds 1 USPTO granted patent. Top assignee: Jilin University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Fang Wang
Introduction
Fang Wang is a notable inventor based in Changchun, China. He has made significant strides in the field of pharmaceuticals, particularly in the development of treatments for inflammatory bowel disease. His work exemplifies the intersection of innovation and healthcare, showcasing the potential of natural compounds in modern medicine.
Latest Patents
Fang Wang holds a patent titled "Use of oleanolic acid-28-O-beta-D-glucopyranoside in preparation of anti-colitis drug." This patent highlights the use of oleanolic acid-28-O-β-D-glucopyranoside, which demonstrates significant anti-ulcerative colitis activity compared to its parent compound, oleanolic acid, and other analogues. The compound has shown equivalent efficacy to Mesalazine, a first-line treatment for inflammatory bowel disease, while also minimizing the risk of salicylic acid anaphylaxis associated with Mesalazine treatment. This innovation presents a promising application in the pharmaceutical industry.
Career Highlights
Fang Wang is affiliated with Jilin University, where he contributes to research and development in the field of medicinal chemistry. His academic background and research focus have positioned him as a key figure in the exploration of natural compounds for therapeutic use. His dedication to advancing medical treatments is evident through his innovative patent.
Collaborations
Fang Wang has collaborated with colleagues such as Caixia Wang and Cuizhu Wang. These partnerships enhance the research environment and foster the exchange of ideas, leading to further advancements in their respective fields.
Conclusion
Fang Wang's contributions to the field of pharmaceuticals, particularly through his patent on oleanolic acid-28-O-β-D-glucopyranoside, highlight the importance of innovation in developing effective treatments for inflammatory bowel disease. His work at Jilin University and collaborations with fellow researchers underscore the collaborative nature of scientific advancement.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile